CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 559,000	$ 1,537,000
Other current assets	20,000	18,000
Total current assets	579,000	1,555,000
Other assets:
Due from related parties	$ 105,000	$ 15,000
Financing Receivable, after Allowance for Credit Loss, Noncurrent, Related Party, Type [Extensible Enumeration]	Related Party [Member]	Related Party [Member]
Investments in unconsolidated entities	$ 187,000	$ 157,000
Total other assets	292,000	172,000
Property and equipment:
Operating lease right-of-use asset	0	20,000
Total property and equipment	0	20,000
TOTAL ASSETS	871,000	1,747,000
Current liabilities:
Operating lease right-of-use liability - current portion	0	23,000
Accounts payable and accrued expenses	21,000	86,000
Income taxes payable	170,000	171,000
Total current liabilities	191,000	280,000
Guarantee liability	11,000	11,000
Total liabilities	202,000	291,000
EQUITY
Common stock - par value $.01; 25,000,000 shares authorized; 7,892,185 and 7,842,185 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively.	79,000	78,000
Additional paid-in capital	2,871,000	2,871,000
Accumulated deficit	(2,380,000)	(1,710,000)
U.S. Neurosurgical Holdings, Inc. stockholders' equity	570,000	1,239,000
Noncontrolling interests	99,000	217,000
Total stockholders' equity	669,000	1,456,000
TOTAL LIABILITIES AND EQUITY	$ 871,000	$ 1,747,000